0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾Ï ȯÀÚÀÇ Äڷγª19 ÆÒµ¥¹Í °ü·Ã ¿ì¿ï, ºÒ¾È, ½ºÆ®·¹½º, Ä¡·á À§±â°¨ÀÌ »îÀÇ Áú¿¡ ¹ÌÄ¡´Â ¿µÇâ

A Study on the Influences of the COVID-19 Pandemic-related Depression, Anxiety, Stress, and Treatment-Crisis on Quality of Life in Cancer Patients

Á¾¾ç°£È£¿¬±¸ 2023³â 23±Ç 1È£ p.19 ~ 28
KMID : 1035120230230010019
±è¼ÒÇü ( Kim So-Hyoung ) - 

ÀÓ°æÈñ ( Lim Kyung-Hee ) - 

Abstract

Purpose: The purpose of this study was to investigate the factors affecting the quality of life of cancer patients by examining the degree of the COVID-19 pandemic-related depression, anxiety, stress, and treatment-crisis.

Methods: Data were collected from 132 cancer patients undergoing surgery, chemotherapy, radiotherapy, and hormone therapy at K University Hospital in D City using a structured questionnaire. The period of data collection was from May 6 to May 28, 2022. The collected data were analyzed using descriptive statistics, t-test, ANOVA, Pearson¡¯s correlation, and stepwise multiple regression.

Results: The mean scores of quality of life, depression, anxiety, stress, and treatment-crisis during the COVID-19 pandemic were 84.64¡¾29.09, 15.14¡¾6.49, 4.66¡¾5.27, 75.83¡¾17.70, and 78.52¡¾19.95, respectively. In terms of factors affecting the quality of life related to the COVID-19 pandemic, COVID-19 pandemic-related stress (¥â=.41, p<.001) appeared to have the greatest impact, followed by COVID-19 pandemic-related treatment-crisis (¥â=.28, p=.002), anxiety (¥â=.21, p=.002), and gender (¥â=.14, p=.009), with a total explanatory power of 67.6%.

Conclusion: To improve the quality of life during the COVID-19 pandemic, COVID-19 pandemic-related stress, treatment-crisis, and anxiety should be periodically monitored and nursing interventions such as education on infection prevention, management, and emotional support programs should be provided to decrease the COVID-19 pandemic-related stress, treatment-crisis, and anxiety.
KeyWords
¾Ï, Äڷγª19, »îÀÇ Áú
Cancer, COVID-19, Quality of life
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed